Article Information
- Received December 26, 2001
- Revision received April 5, 2002
- Accepted April 23, 2002
- First published July 15, 2002.
- Version of record published July 15, 2002.
Author Information
- 1Department of Neurology, University Hospital, 3010 Bern, Switzerland,
- 2Area of Psychobiology, University Jaume I, E-12080 Castellón, Spain, and
- 3Department of Brain and Cognitive Sciences and the McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
Author contributions
Disclosures
- Received December 26, 2001.
- Revision received April 5, 2002.
- Accepted April 23, 2002.
This work was supported by National Institute of Neurological Disorders and Stroke Grants NS25529 and NS38372, National Institute on Drug Abuse Grant DA08037, the National Parkinson's Foundation, the Stanley Foundation, the Swiss National Science Foundation, and the Science and Technology Ministry of Spain. We thank Patricia Harlan and Henry F. Hall for their expert help with the experiments, Dr. Paul DiZio for his help with data analysis, and Dr. Esen Saka Topcuoglu for her insightful comments on this manuscript.
Correspondence should be addressed to Dr. Ann M. Graybiel, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, E25-618, 45 Carleton Street, Cambridge, MA 02139. E-mail:graybiel{at}mit.edu.
Online Impact